South Korea · Delayed Price · Currency is KRW Kolon Life Science Statistics
Total Valuation
KOSDAQ:102940 has a market cap or net worth of KRW 190.60 billion. The enterprise value is 316.24 billion.
| Market Cap | 190.60B |
| Enterprise Value | 316.24B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KOSDAQ:102940 has 13.09 million shares outstanding. The number of shares has increased by 19.97% in one year.
| Current Share Class | 13.09M |
| Shares Outstanding | 13.09M |
| Shares Change (YoY) | +19.97% |
| Shares Change (QoQ) | -25.88% |
| Owned by Insiders (%) | 17.14% |
| Owned by Institutions (%) | 0.27% |
| Float | 7.60M |
Valuation Ratios
The trailing PE ratio is 6.06.
| PE Ratio | 6.06 |
| Forward PE | n/a |
| PS Ratio | 0.90 |
| PB Ratio | 0.27 |
| P/TBV Ratio | 0.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 9.13 |
| EV / Sales | 1.50 |
| EV / EBITDA | 11.06 |
| EV / EBIT | 17.21 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.76, with a Debt / Equity ratio of 0.23.
| Current Ratio | 0.76 |
| Quick Ratio | 0.36 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 5.50 |
| Debt / FCF | -2.67 |
| Interest Coverage | 2.76 |
Financial Efficiency
Return on equity (ROE) is 7.12% and return on invested capital (ROIC) is 2.12%.
| Return on Equity (ROE) | 7.12% |
| Return on Assets (ROA) | 1.37% |
| Return on Invested Capital (ROIC) | 2.12% |
| Return on Capital Employed (ROCE) | 2.10% |
| Weighted Average Cost of Capital (WACC) | 4.81% |
| Revenue Per Employee | 497.50M |
| Profits Per Employee | 81.48M |
| Employee Count | 425 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 2.43 |
Taxes
In the past 12 months, KOSDAQ:102940 has paid 527.03 million in taxes.
| Income Tax | 527.03M |
| Effective Tax Rate | 1.50% |
Stock Price Statistics
The stock price has decreased by -49.88% in the last 52 weeks. The beta is 0.20, so KOSDAQ:102940's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | -49.88% |
| 50-Day Moving Average | 25,028.40 |
| 200-Day Moving Average | 47,036.35 |
| Relative Strength Index (RSI) | 29.15 |
| Average Volume (20 Days) | 182,289 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KOSDAQ:102940 had revenue of KRW 211.44 billion and earned 34.63 billion in profits. Earnings per share was 2,403.02.
| Revenue | 211.44B |
| Gross Profit | 58.38B |
| Operating Income | 18.37B |
| Pretax Income | 35.16B |
| Net Income | 34.63B |
| EBITDA | 28.58B |
| EBIT | 18.37B |
| Earnings Per Share (EPS) | 2,403.02 |
Balance Sheet
The company has 31.70 billion in cash and 157.33 billion in debt, with a net cash position of -125.64 billion or -9,597.58 per share.
| Cash & Cash Equivalents | 31.70B |
| Total Debt | 157.33B |
| Net Cash | -125.64B |
| Net Cash Per Share | -9,597.58 |
| Equity (Book Value) | 696.93B |
| Book Value Per Share | 53,250.43 |
| Working Capital | -50.58B |
Cash Flow
In the last 12 months, operating cash flow was -31.22 billion and capital expenditures -27.79 billion, giving a free cash flow of -59.01 billion.
| Operating Cash Flow | -31.22B |
| Capital Expenditures | -27.79B |
| Depreciation & Amortization | 10.21B |
| Net Borrowing | 34.19B |
| Free Cash Flow | -59.01B |
| FCF Per Share | -4,507.75 |
Margins
Gross margin is 27.61%, with operating and profit margins of 8.69% and 16.38%.
| Gross Margin | 27.61% |
| Operating Margin | 8.69% |
| Pretax Margin | 16.63% |
| Profit Margin | 16.38% |
| EBITDA Margin | 13.52% |
| EBIT Margin | 8.69% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.65, which amounts to a dividend yield of 0.02%.
| Dividend Per Share | 2.65 |
| Dividend Yield | 0.02% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.97% |
| Shareholder Yield | -19.96% |
| Earnings Yield | 18.17% |
| FCF Yield | -30.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 27, 2017. It was a forward split with a ratio of 1.5.
| Last Split Date | Dec 27, 2017 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
KOSDAQ:102940 has an Altman Z-Score of 0.87 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.87 |
| Piotroski F-Score | 4 |